Trends in Neurosciences,
Journal Year:
2025,
Volume and Issue:
48(1), P. 47 - 61
Published: Jan. 1, 2025
Despite
the
substantial
contribution
of
disruptions
in
GABAergic
inhibitory
neurotransmission
to
etiology
psychiatric,
neurodevelopmental,
and
neurodegenerative
disorders,
surprisingly
few
drugs
targeting
system
are
currently
available,
partly
due
insufficient
understanding
circuit-specific
synapse
biology.
In
addition
GABA
receptors,
synapses
contain
an
elaborate
organizational
protein
machinery
that
regulates
properties
synaptic
transmission.
Until
recently,
this
remained
largely
unexplored,
but
key
methodological
advances
have
now
led
identification
a
wealth
new
organizer
proteins.
Notably,
many
these
proteins
appear
function
only
at
specific
subsets
synapses,
creating
diversity
complexes
may
serve
as
targets
for
pharmacotherapies.
The
present
review
aims
summarize
developments
underlie
newfound
knowledge
provide
current
overview
synapse-specific
complexes,
well
outlining
future
avenues
challenges
translating
into
clinical
applications.
Neuron,
Journal Year:
2022,
Volume and Issue:
110(15), P. 2438 - 2454.e8
Published: June 13, 2022
GluN3A
is
an
atypical
glycine-binding
subunit
of
NMDA
receptors
(NMDARs)
whose
actions
in
the
brain
are
mostly
unknown.
Here,
we
show
that
expression
subunits
controls
excitability
mouse
adult
cortical
and
amygdalar
circuits
via
unusual
signaling
mechanism
involving
formation
excitatory
glycine
GluN1/GluN3A
(eGlyRs)
their
tonic
activation
by
extracellular
glycine.
eGlyRs
extrasynaptic
reside
specific
neuronal
populations,
including
principal
cells
basolateral
amygdala
(BLA)
SST-positive
interneurons
(SST-INs)
neocortex.
In
BLA,
eGlyR
currents
sensitive
to
fear-conditioning
protocols,
subject
neuromodulation
dopaminergic
system,
control
stability
fear
memories.
neocortex,
vivo
spiking
SST-INs
behavior-dependent
modulation
activity.
GluN3A-containing
thus
represent
a
novel
widespread
modality
brain,
with
attributes
strikingly
depart
from
those
conventional
NMDARs.
Neuron,
Journal Year:
2023,
Volume and Issue:
111(12), P. 1876 - 1886.e5
Published: April 21, 2023
The
superficial
superior
colliculus
(sSC)
carries
out
diverse
roles
in
visual
processing
and
behaviors,
but
how
these
functions
are
delegated
among
collicular
neurons
remains
unclear.
Here,
using
single-cell
transcriptomics,
we
identified
28
neuron
subtypes
subtype-enriched
marker
genes
from
tens
of
thousands
adult
mouse
sSC
neurons.
We
then
asked
whether
the
sSC's
molecular
tuned
to
different
stimuli.
Specifically,
imaged
calcium
dynamics
single
vivo
during
stimulation
mapped
gene
transcripts
onto
same
ex
vivo.
Our
results
identify
a
subtype
inhibitory
accounting
for
∼50%
direction-selective
cells,
suggesting
genetic
logic
functional
organization
sSC.
In
addition,
our
studies
provide
comprehensive
atlas
multimodal
mapping
method
that
will
facilitate
investigation
their
respective
functions,
connectivity,
development.
Neuron,
Journal Year:
2023,
Volume and Issue:
111(18), P. 2863 - 2880.e6
Published: July 13, 2023
Changes
in
the
function
of
inhibitory
interneurons
(INs)
during
cortical
development
could
contribute
to
pathophysiology
neurodevelopmental
disorders.
Using
all-optical
vivo
approaches,
we
find
that
parvalbumin
(PV)
INs
and
their
immature
precursors
are
hypoactive
transiently
decoupled
from
excitatory
neurons
postnatal
mouse
somatosensory
cortex
(S1)
Fmr1
KO
mice,
a
model
fragile
X
syndrome
(FXS).
This
leads
loss
(PV-INs)
both
mice
humans
with
FXS.
Increasing
activity
future
PV-INs
neonatal
restores
PV-IN
density
ameliorates
transcriptional
dysregulation
S1,
but
not
circuit
dysfunction.
Critically,
administering
an
allosteric
modulator
Kv3.1
channels
after
S1
critical
period
does
rescue
dynamics
tactile
defensiveness.
Symptoms
FXS
related
disorders
be
mitigated
by
targeting
PV-INs.
Trends in Neurosciences,
Journal Year:
2025,
Volume and Issue:
48(1), P. 47 - 61
Published: Jan. 1, 2025
Despite
the
substantial
contribution
of
disruptions
in
GABAergic
inhibitory
neurotransmission
to
etiology
psychiatric,
neurodevelopmental,
and
neurodegenerative
disorders,
surprisingly
few
drugs
targeting
system
are
currently
available,
partly
due
insufficient
understanding
circuit-specific
synapse
biology.
In
addition
GABA
receptors,
synapses
contain
an
elaborate
organizational
protein
machinery
that
regulates
properties
synaptic
transmission.
Until
recently,
this
remained
largely
unexplored,
but
key
methodological
advances
have
now
led
identification
a
wealth
new
organizer
proteins.
Notably,
many
these
proteins
appear
function
only
at
specific
subsets
synapses,
creating
diversity
complexes
may
serve
as
targets
for
pharmacotherapies.
The
present
review
aims
summarize
developments
underlie
newfound
knowledge
provide
current
overview
synapse-specific
complexes,
well
outlining
future
avenues
challenges
translating
into
clinical
applications.